Bodini, G. et al. Therapeutic Drug Monitoring in Crohn’s Disease Patients, A Comparison Between Homogenous Mobility Shift Assay and Point of Care Method. UEGW 2019, Feb 09 – 11, 2018. Barcelona, Spain. P1750.
BÜHLMANN Quantum Blue® IFX is for Research Use Only in the US. Not for use in diagnostic procedures in the US.
Health Canada License: 98838
Welcome to the website of Buhlmann Diagnostics Corp. By continuing your visit to our website you will be deemed to have accepted the Terms of Use. If you don't wish to accept the Terms of Use please discontinue your visit. OK
